AbbVie Bengaluru Staff Volunteer to Empower Young Students in Annual Event
Bengaluru, July 1st, 2024 – AbbVie, a global biopharmaceutical company focused on creating medicines and…
Global biopharmaceutical company
China CDE Approves Global Phase III Study of Olverembatinib for SDH-Deficient GIST
SUZHOU, China, and ROCKVILLE, Md., June 11, 2024 — Ascentage Pharma (6855.HK), a global biopharmaceutical…